Free Trial

Canopy Growth Co. (NASDAQ:CGC) Sees Large Increase in Short Interest

Canopy Growth logo with Medical background

Canopy Growth Co. (NASDAQ:CGC - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 9,760,000 shares, a growth of 6.2% from the November 30th total of 9,190,000 shares. Based on an average daily volume of 5,800,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 10.0% of the company's shares are sold short.

Analysts Set New Price Targets

Separately, Atb Cap Markets lowered Canopy Growth from a "hold" rating to a "strong sell" rating in a research report on Monday, December 16th.

Read Our Latest Report on Canopy Growth

Canopy Growth Stock Performance

NASDAQ:CGC remained flat at $2.74 on Wednesday. 4,574,971 shares of the company's stock were exchanged, compared to its average volume of 7,400,490. The stock has a market capitalization of $298.50 million, a price-to-earnings ratio of -0.56 and a beta of 0.83. Canopy Growth has a twelve month low of $2.65 and a twelve month high of $14.92. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.39 and a quick ratio of 1.07. The firm has a fifty day moving average of $3.84 and a 200 day moving average of $5.13.

Institutional Investors Weigh In On Canopy Growth

Several large investors have recently modified their holdings of the company. PFG Investments LLC bought a new stake in Canopy Growth in the third quarter worth approximately $54,000. Sassicaia Capital Advisers LLC bought a new stake in shares of Canopy Growth in the 3rd quarter valued at $54,000. Financial Advocates Investment Management acquired a new position in shares of Canopy Growth during the 3rd quarter valued at $57,000. CIBC Asset Management Inc bought a new position in Canopy Growth during the second quarter worth $91,000. Finally, Vontobel Holding Ltd. acquired a new stake in Canopy Growth in the third quarter worth $92,000. 3.33% of the stock is currently owned by institutional investors and hedge funds.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines